TOP2A and colorectal carcinoma: In a study of the frequency of TOP2A gene aberrations in CRC tissue, we found that a total of 10.5 % of the patients had a TOP2A/CEN-17 ratio ≥ 1.5, which is compatible with TOP2A amplification [23].